Investigational vertebroplasty efficacy and safety trial: Detailed analysis of blinding efficacy

Radiology

Volumn 257, Issue 1, 2010, Pages 219-225

  Brinjikji, Waleed ^a   Comstock, Bryan A ^c   Heagerty, Patrick J ^c   Jarvik, Jeffrey G ^d   Kallmes, David F ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; OUTCOME ASSESSMENT; PERCUTANEOUS VERTEBROPLASTY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RADIOLOGIST; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STUDENT T TEST;

CROSS-OVER STUDIES; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; QUESTIONNAIRES; RESEARCH DESIGN; SPINAL FRACTURES; VERTEBROPLASTY;

EID: 77957378174     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100094     Document Type: Article

References (17)

1. Fisher CG, Wood KB. Introduction to and techniques of evidence-based medicine. Spine (Phila Pa 1976) 2007;32(19 suppl):S66-S72.
2. Wright JG. Placebo surgery research: a blinding imperative. J Clin Epidemiol 2007;60(5):536; author reply 536.
3. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134(8):663-694. (Pubitemid 32322245)
4. Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390.
5. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-46. (Pubitemid 32682008)
6. Spanos NP, Burgess CA, Cross PA, MacLeod G. Hypnosis, reporting bias, and suggested negative hallucinations. J Abnorm Psychol 1992;101(1):192-199.
7. Gray LA, Jarvik JG, Heagerty PJ, et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disord 2007;8:126.
8. Kallmes DF, Comstock BA, Heagerty PJ, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009;361(6):569-579.
9. McRae C, Cherin E, Yamazaki TG, et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 2004;61(4):412-420. (Pubitemid 38451551)
10. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003;54(3):403-414.
11. Patrick DL, Deyo RA, Atlas SJ, Singer DE, Chapin A, Keller RB. Assessing health-related quality of life in patients with sciatica. Spine (Phila Pa 1976) 1995;20(17):1899-1908; discussion 1909.
12. Trout AT, Kallmes DF, Gray LA, et al. Evaluation of vertebroplasty with a validated outcome measure: the Roland-Morris Disability Questionnaire. AJNR Am J Neuroradiol 2005;26(10):2652-2657.
13. Diamond TH, Bryant C, Browne L, Clark WA. Clinical outcomes after acute osteoporotic vertebral fractures: a 2-year non-randomised trial comparing percutaneous vertebroplasty with conservative therapy. Med J Aust 2006;184(3):113-117. (Pubitemid 43256911)
14. Diamond TH, Champion B, Clark WA. Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebroplasty with conservative therapy. Am J Med 2003;114(4):257-265. (Pubitemid 36398069)
15. Wardlaw D, Cummings SR, Van Meirhaeghe J, et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet 2009;373(9668):1016-1024.
16. Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Control Clin Trials 2004;25(2):143-156.
17. James KE, Bloch DA, Lee KK, Kraemer HC, Fuller RK. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation - a VA cooperative study. Stat Med 1996;15(13):1421-1434.